# Trastuzumab Deruxtecan in Advanced Breast Cancer

> **NCT07180264** · — · RECRUITING · sponsor: **Wenjin Yin** · enrollment: 118 (estimated)

## Conditions studied

- Advanced Breast Cancer

## Interventions

- **DRUG:** Trastuzumab deruxtecan

## Key facts

- **NCT ID:** NCT07180264
- **Lead sponsor:** Wenjin Yin
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-28
- **Primary completion:** 2027-02
- **Final completion:** 2029-02
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07180264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07180264, "Trastuzumab Deruxtecan in Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07180264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*